...
首页> 外文期刊>Scandinavian journal of urology >Single-center study: the diagnostic performance of contrast-enhanced ultrasound (CEUS) for assessing renal oncocytoma
【24h】

Single-center study: the diagnostic performance of contrast-enhanced ultrasound (CEUS) for assessing renal oncocytoma

机译:单中心研究:对比增强超声(CEUS)的诊断性能进行评估肾癌肾癌瘤

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: The aim of the present retrospective single-center study is to evaluate the diagnostic performance of contrast-enhanced ultrasound (CEUS) in the evaluation of renal oncocytoma. Method: Thirteen patients with histopathologically confirmed renal oncocytoma and 26 patients with histopathologically confirmed renal cell carcinoma were included in this retrospective single-center study on whom CEUS was performed between 2005 and 2015. The applied contrast agent was a second-generation blood pool agent. CEUS examinations were performed and interpreted by a single radiologist with more than 15 years of experience (EFSUMB Level 3). Results: CEUS examinations were successfully performed in all included patients without any adverse effects. Renal oncocytomas showed varying echogenicity (46% hypoechoic, 23% hyperechoic, 8% iso-/hyperechoic, 8% isoechoic). In two cases renal oncocytoma only demarcated upon i.v. application of contrast medium. In bilateral oncocytosis, lesions presented as hyperechoic. Only 23% of renal oncocytomas showed slight vascularization using Color Doppler. No oncocytoma-specific pattern of microperfusion could be elucidated: 85% of the oncocytomas presented hyperenhancing, of whom 50% also showed delayed venous wash-out; 8% of renal oncocytomas showed venous wash-out without early arterial hyperenhancement. Conclusions: Within the frame of the present study and in line with the recent state of knowledge, no specific sonomorphological feature - including CEUS - could be detected allowing for adequate discrimination between oncocytoma and renal cell carcinoma.
机译:目的:本发明的目的的目的是评估对比增强超声(CEUS)在评估肾儿肾细胞瘤的诊断性能。方法:13例组织病理学证经肾癌瘤和26例组织病理学证实肾细胞癌的患者均包含在2005年至2015年间CEUS的回顾性单中心研究中。应用的造影剂是第二代血吸剂。通过一个超过15年经验的单一放射科医生进行CEUS考试(EFSUMB 3级)。结果:在所有患者中成功进行CEUS检查,没有任何不良影响。肾心弓瘤显示出不同的回声(46%的低氧焦,23%的高档,8%Iso-/ Hyperococoic,8%Isoechoic)。在两种情况下,肾心肌瘤仅划定在I.v.造影剂的应用。在双侧吞咽病症中,病变呈现为高档。只有23%的肾心电图瘤使用颜色多普勒显示出轻微的血管形成。不能阐明不细胞瘤特异性微孔,可以阐明:85%的血管瘤呈血红素血管瘤,其中50%也显示出延迟的静脉冲洗; 8%的肾心阳瘤表现出没有早期动脉Hyperencement的静脉洗脱。结论:在本研究的框架内和符合最近的知识状态,没有特定的典型特征 - 包括CEUS - 可以检测到允许在细胞瘤和肾细胞癌之间进行充分的歧视。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号